';
Policy Areas

On September 23, 2025, the Centers for Medicare and Medicaid Services (CMS) issued a policy clarification related to the qualifications for speech-language pathologists (SLP) when furnishing Part B outpatient therapy services.

These Part B services include speech-language pathology services that:

  1. Are furnished by SLPs in private practice (SLPPPs) who submit professional claims; and
  2. Are furnished and billed by providers of outpatient therapy services as defined at 42CFR489.2.

The Office of Developmental Programs (ODP) has shared ODPANN 25-089. This announcement is:

  • To share a reminder on Medication Administration Training Requirements
  • To announce the Face-to-Face training schedule for October through December 2025.

Please view the information in the announcement for details, including training dates and registration information.

Flag of Pennsylvania state united states of america

Pennsylvania will receive more than $83 million from the Substance Abuse and Mental Health Services Administration (SAMHSA) in State Opioid Response (SOR) grant funding, which provides critical resources to states and Tribal communities to address the overdose crisis through prevention, opioid overdose reversal medications, treatment (including medications for opioid use disorder [MOUD]) and recovery support. On Monday, the U.S. Department of Health and Human Services (HHS), through SAMHSA, announced a total allocation of more than $1.5 billion in Fiscal Year 2025 continuation funding for SOR and Tribal Opioid Response (TOR) grants, with $1.48 billion committed to SOR and nearly $63 million committed to TOR.

This most recent round of funding is the second year of the three-year SOR IV grant cycle, which began October 1, 2024, and runs through September 30, 2027. The Pennsylvania Department of Drug and Alcohol Programs (DDAP) manages and distributes SOR funding, which comprises a significant percentage of DDAP’s annual budget.

Since the SOR program began in 2018, states report that nearly 1.3 million people have received treatment services, including more than 650,000 who received MOUD. Through the SOR program, nearly 1.5 million people have received recovery support services. SAMHSA grantees reported distributing more than 10 million opioid overdose reversal kits, with opioid overdose reversal medications being used to reverse more than 550,000 overdoses. Since the TOR program began in 2018, Tribes report that approximately 16,500 patients have received treatment services, and SAMHSA grantees reported distributing more than 116,500 naloxone kits, with opioid reversal medications being used to reverse more than 1,750 overdoses.

Read SAMHA’s press release.

The American Association for the Treatment of Opioid Dependence (AATOD) is hosting a free webinar from 12:30 pm – 2:00 pm Wednesday, September 24, on states’ and treatment providers’ response to the Substance Abuse and Mental Health Administration’s updated regulations governing opioid treatment programs (OTP). The updated regulations, in place since October 2024, are intended to increase accessibility to and flexibility within OTPs, including methadone treatment for opioid use disorder.

Registration for the webinar is required.

The webinar builds on the July 2025 presentation that provided guidance to OTPs on the updated regulations. Presenters will share how states and treatment providers are complying with the regulations and how patients have benefited through increased access, retention, and treatment flexibility.

The discussion will serve as a prelude to AATOD’s policy discussions at the upcoming national conference in Philadelphia, October 4 – 8, 2025.

The webinar will also be available on-demand via the AATOD website. Certificates of Attendance will be provided upon request. For questions, email AATOD.

This forum will be held to support provider preparedness. The Office of Development Programs (ODP) will review the quarterly forums and discuss data presented to the Information Sharing and Advisory Committee (ISAC) Provider Performance Review Subcommittee. ODP will also review the emerging themes or trends developing with the implementation of performance-based contracting.

Audience: Residential Providers

Date: December 22, 2025, 1:00 pm – 2:30 pm

Register Here

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is providing the opportunity for public comment on the Pennsylvania Substance Use Prevention, Treatment, and Recovery Services (SUPTRS) Block Grant application. This application will occur in three parts:

  • Substance Abuse Prevention and Treatment Assessment and Plan
  • SUPTRS Report (available in November)
  • Annual Synar Report (available in December)

The application documents can be accessed through SAMHSA’s Web Block Grant Application System (WebBGAS) using the login “citizenpa” and password “citizen.”

Please submit your comments by Tuesday, September 30.

The agenda for the October 1, 2025, virtual Long-Term Services and Supports (LTSS) Subcommittee meeting has been released. The meeting will be held from 10:00 am – 1:00 pm. Information specific to this meeting is below:

Comments and questions should be sent electronically.

0 2080

On September 24, 2025, WellSky will be conducting a webinar on the fiscal year (FY) 2026 inpatient rehabilitation facility prospective payment system (IRF PPS) final rule that was released by the Centers for Medicare and Medicaid Services (CMS) in early August. The webinar will begin at 12:00 pm. There is no cost to participate in this webinar.

Topics will include:

  • The key changes in the 2026 IRF Final Rule impacting reimbursement;
  • The technical changes and their indirect effects on your program;
  • The amendments to the QRP and the appeal process; and
  • The latest concerns about potential IRF reimbursement denials.

To participate in the webinar, register here.